eye treatment biosimilar
Scope
Date
~
-
Biosimilars
Samsung Bioepis gets FDA approval for Lucentis biosimilar Byooviz
Samsung Bioepis Co., a leading South Korean biopharmaceutical company, has received approval from the US Food and Drug Administration for its Byoovi...
Sep 23, 2021 (Gmt+09:00)
-
Future mobility
SK's car-sharing service SoCar Malaysia sees valuation top $210 mn
Car-sharing platform SoCar Mobility Malaysia has raised around 65 billion won ($55.6 million) from South Korean private equity firm EastBridge Partn...
Sep 16, 2021 (Gmt+09:00)
-
Pharmaceuticals
High-priced drugs add to pressure for Korea's healthcare reform
A number of new rare disease treatments, approved in South Korea over the past year, are still unaffordable for the public because of their price ta...
Sep 15, 2021 (Gmt+09:00)
-
Petrochemicals
DL Chem to spend $2 bn on petrochemical expansion
DL Chemical Co., the petrochemical arm of South Korea's DL Group, will spend 2 trillion won ($1.7 billion) over the next five years to sharply boost...
Sep 12, 2021 (Gmt+09:00)
language -
Automobiles
Hyundai mulls robot dog Spot for facility inspector job
South Korea's largest carmaker Hyundai Motor Group is considering employing Spot, the four-legged robot developed by Boston Dynamics Inc., in its ...
Sep 10, 2021 (Gmt+09:00)
-
Korean startups
Streaming platform Mahocast eyes listing on Japan's Mothers market
TOKYO -- Japan-based concert streaming platform Mahocast, dubbed as the Netflix for concerts in Japan, is gaining attention as a venue for both musi...
Sep 07, 2021 (Gmt+09:00)
-
Mergers & Acquisitions
Burger King's Korea, Japan operations up for sale
Affinity Equity Partners is putting Burger King's operations in South Korea and Japan up for sale, after the US hamburger franchise overtook its big...
Sep 06, 2021 (Gmt+09:00)
language -
Non-ferrous metals
Korea Zinc emerges winner despite sharp decline in treatment fees
Just like many other manufacturers around the world, 2020 was a turbulent year for Korea Zinc Co., the world’s largest lead and zinc smelter.T...
Sep 05, 2021 (Gmt+09:00)
language -
Biotech
Korea’s bio startup Voronoi inks $324 million deal with Brickell Biotech
Voronoi Inc., a South Korean biotechnology startup, has clinched a $324 million deal to grant Brickell Biotech, a US clinical-stage pharmaceutical f...
Sep 02, 2021 (Gmt+09:00)
language -
Hydrogen economy
SK E&S eyes $30 billion corporate value as top hydrogen company
SK E&S Co., the natural gas business unit of SK Group, aims to turn into an eco-friendly company with an enterprise value of 35 trillion won ($3...
Sep 01, 2021 (Gmt+09:00)
language -
Chief Executives
Govt pension fund eyes real estate in non-core areas
South Korea's Government Employees Pension Service (GEPS) is setting its sights on overseas office buildings not only in core regions but in its per...
Aug 25, 2021 (Gmt+09:00)
-
Chief Executives
Father of Krafton's PUBG eyes the expansion of games
In September 2020, Krafton Inc.’s blockbuster game PlayerUnknown’s Battlegrounds (PUBG) hit a major roadblock. India prohibited Chinese ...
Aug 24, 2021 (Gmt+09:00)
language -
Tech, Media & Telecom
Samsung to invest $200 bn over next 3 yrs, including M&As
Samsung Group will invest a combined 240 trillion won ($206 billion) over the next three years in its core businesses such as semiconductor, display...
Aug 24, 2021 (Gmt+09:00)
language -
Biosimilars
Samsung Bioepis gets nod for sale of ophthalmology biosimilar in Europe
South Korea’s biopharmaceutical company Samsung Bioepis Co. won approval from European authorities for sale of Byooviz, its ophthalmology bios...
Aug 23, 2021 (Gmt+09:00)
language -
Covid-19 treatment
Brazil gives emergency use nod for Celltrion’s COVID-19 treatment
South Korean drugmaker Celltrion Inc. has added Brazil to the list of countries that have granted emergency use approval for its COVID-19 treatment ...
Aug 13, 2021 (Gmt+09:00)
language -
Korean startups
Baby Shark creator eyes 2022 listing, begins due diligence
South Korea-based edtech startup SmartStudy, the creator of YouTube's current most-viewed video, Pinkfong Baby Shark Dance, has begun preparations f...
Aug 13, 2021 (Gmt+09:00)
-
Korean games
Nexon reveals upcoming 'super' games, eyes entertainment IPs
South Korea's leading game company Nexon Co. has unveiled a massive lineup of super games in development alongside plans to expand its intellectual ...
Aug 06, 2021 (Gmt+09:00)
language -
IPOs
Krafton locks up two-thirds of IPO shares amid price concerns
Krafton Inc. has locked up more than 80% of its IPO shares allocated to institutional investors, in a move to prevent mass selling of its shares imm...
Aug 05, 2021 (Gmt+09:00)
-
COVID-19
Celltrion to enter clinical trials of new COVID-19 treatment
South Korean biosimilar maker Celltrion Inc. will launch the first-phase clinical trials of its new COVID-19 treatment candidate next month, followi...
Aug 05, 2021 (Gmt+09:00)
language -
Korean chipmakers
Chip supercycle view revives with DRAM, NAND prices at multi-year highs
The contract prices of memory chip prices are hovering around multi-year high levels, fanning the view that the global semiconductor market is enter...
Jul 30, 2021 (Gmt+09:00)
language -
COVID-19
COVID treatment deals drive Samsung Bio’s record quarterly earnings
South Korea’s Samsung Biologics Co. posted its highest quarterly revenue and operating profit, thanks largely to a number of long-term manufac...
Jul 28, 2021 (Gmt+09:00)
-
IPOs
Tencent, Korea Value poised to see sixfold return from KakaoBank
Chinese technology giant Tencent Holdings, Korea Value Asset Management Co. and South Korea's top lender Kookmin Bank are among a group of sharehold...
Jul 27, 2021 (Gmt+09:00)
language -
Biotech
IMB Dx eyes platform to detect stage 1 cancer with single draw of blood
IMB Dx Inc., a South Korean biotechnology startup focusing on diagnostic devices, plans to develop a platform that can detect early-stage cancer wit...
Jul 22, 2021 (Gmt+09:00)
-
Biosimilars
Korean drugmakers race to release Stelara biosimilars
South Korea’s major drugmakers such as Celltrion Inc., Samsung Bioepis and Dong-A St are going for broke to release biosimilars of Stelara, Jo...
Jul 22, 2021 (Gmt+09:00)
language -
Korean startups
4by4's AI solution for high-def video content lures metaverse players
Displays are everywhere – refrigerators, automobiles, and even robots. And this display boom has sparked a fresh opportunity for 4by4 Inc., a ...
Jul 21, 2021 (Gmt+09:00)
-
Covid-19 treatment
Indonesia grants emergency use approval for Celltrion’s COVID-19 treatment
South Korean drugmaker Celltrion Inc. has received the Indonesian government’s permission for restricted use of its COVID-19 treatment Regkiro...
Jul 20, 2021 (Gmt+09:00)
-
Pre-IPOs
Masayoshi Son's top pick Yanolja eyes 2023 Nasdaq listing
South Korea's largest travel platform Yanolja has raised 2 trillion won ($1.7 billion) from the Masayoshi Son-led SoftBank Vision Fund II, marking t...
Jul 15, 2021 (Gmt+09:00)
language -
Waste management
The power of rubbish: Korean firms make big money from garbage
There is money to be made in garbage. Such is the growing consensus among investors as well as waste treatment companies amid tighter environmental ...
Jul 15, 2021 (Gmt+09:00)
language -
IPOs
7brau becomes Korea's second craft brewery en route to IPO
South Korea-based Seven Brau Co., or 7brau, is poised to become the country's second craft brewery to make a trading debut, following the footsteps ...
Jul 14, 2021 (Gmt+09:00)
-
COVID-19
Celltrion’s COVID-19 treatment reduces incidence of severity by 70%
Celltrion Inc. on July 13 said that its COVID-19 treatment Regkirona has proven effective in reducing the incidence of severe cases of the virus by ...
Jul 13, 2021 (Gmt+09:00)
language